• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性甲状旁腺功能亢进症中骨形成和骨吸收的生化标志物增加,特别提及轻症患者。

Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.

作者信息

Valdemarsson S, Lindergård B, Tibblin S, Bergenfelz A

机构信息

Department of Internal Medicine, Lund University Hospital, Sweden.

出版信息

J Intern Med. 1998 Feb;243(2):115-22. doi: 10.1046/j.1365-2796.1998.00241.x.

DOI:10.1046/j.1365-2796.1998.00241.x
PMID:9566639
Abstract

OBJECTIVES

To evaluate the impact on bone turnover of primary hyperparathyroidism (pHPT) with special reference to patients with mild pHPT, using biochemical markers of bone formation and resorption.

DESIGN

A longitudinal study of patients with pHPT before and one year after surgical treatment.

SETTING

The Departments of Internal Medicine and Surgery, Lund University Hospital.

SUBJECTS

Forty consecutive patients with pHPT. Thirty of these patients had mild pHPT and are reported separately. Data on bone mineral was also compared to a reference population.

INTERVENTION

All patients were operated upon and restudied one year later.

MAIN OUTCOME MEASURES

Bone resorption and formation was studied by means of the serum concentrations of the telopeptide of the carboxyterminal region of type 1 collagen (ICTP) and of alkaline phosphatase (ALP), osteocalcin and the carboxyterminal propeptide of type 1 procollagen (PICP), respectively. Bone density was measured at the distal radius by single photon absorptiometry (SPA).

RESULTS

Bone formation markers consistently decreased after parathyroid surgery: ALP from 3.51 +/- 0.23 to 2.94 +/- 0.21 microkat L(-1) (P < 0.05), osteocalcin from 6.15 +/- 0.53 to 2.89 +/- 0.23 microg L(-1) (P < 0.001) and PICP from 126.4 +/- 10.9 to 96.0 +/- 6.5 microg L(-1) (P < 0.001). In parallel, the ICTP concentration, reflecting bone resorption, decreased from 5.10 +/- 0.54 to 3.94 +/- 0.34 microg L(-1) (P < 0.001). There was not any significant change in distal radius bone mineral 1 one year after surgery. In the subgroup of patients classified as mild pHPT, a significant decrease was noted for osteocalcin, PICP and for ICTP but not for ALP, without significant changes in variables reflecting distal radius bone mineral content. Glomerular filtration rate was inversely correlated to serum levels of intact PTH, ionized calcium, alkaline phosphatase, osteocalcin and ICTP and directly correlated to the 1.25-dihydroxy-vitamin D concentrations.

CONCLUSIONS

pHPT is associated with substantial changes in circulating levels of biochemical markers of bone formation and resorption. These findings are also present in patients with mild pHPT. Renal function should be considered in the evaluation of the impact of pHPT on bone turnover.

摘要

目的

使用骨形成和骨吸收的生化标志物,评估原发性甲状旁腺功能亢进症(pHPT)对骨转换的影响,尤其关注轻度pHPT患者。

设计

对pHPT患者手术治疗前后进行的纵向研究。

地点

隆德大学医院内科和外科。

研究对象

40例连续的pHPT患者。其中30例为轻度pHPT患者,已单独报告。还将骨矿物质数据与参考人群进行了比较。

干预措施

所有患者均接受手术治疗,并在一年后再次进行研究。

主要观察指标

分别通过1型胶原蛋白羧基末端区域的端肽(ICTP)和碱性磷酸酶(ALP)、骨钙素以及1型前胶原羧基末端前肽(PICP)的血清浓度来研究骨吸收和骨形成。采用单光子吸收法(SPA)测量桡骨远端的骨密度。

结果

甲状旁腺手术后,骨形成标志物持续下降:ALP从3.51±0.23降至2.94±0.21微卡特/升(P<0.05),骨钙素从6.15±0.53降至2.89±0.23微克/升(P<0.001),PICP从126.4±10.9降至96.0±6.5微克/升(P<0.001)。同时,反映骨吸收的ICTP浓度从5.10±0.54降至3.94±0.34微克/升(P<0.001)。术后一年桡骨远端骨矿物质无显著变化。在分类为轻度pHPT的患者亚组中,骨钙素、PICP和ICTP显著下降,但ALP未下降,反映桡骨远端骨矿物质含量的变量无显著变化。肾小球滤过率与完整甲状旁腺激素、离子钙、碱性磷酸酶、骨钙素和ICTP的血清水平呈负相关,与1,25-二羟维生素D浓度呈正相关。

结论

pHPT与骨形成和骨吸收生化标志物的循环水平显著变化有关。这些发现也存在于轻度pHPT患者中。在评估pHPT对骨转换的影响时应考虑肾功能。

相似文献

1
Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.原发性甲状旁腺功能亢进症中骨形成和骨吸收的生化标志物增加,特别提及轻症患者。
J Intern Med. 1998 Feb;243(2):115-22. doi: 10.1046/j.1365-2796.1998.00241.x.
2
Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.甲状旁腺切除术后骨量及骨代谢血清标志物的变化
Surgery. 1997 Nov;122(5):882-7. doi: 10.1016/s0039-6060(97)90328-7.
3
Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.通过新开发的骨代谢标志物预测肾性甲状旁腺功能亢进症的骨量:评估血清I型胶原羧基末端吡啶啉交联终肽和I型前胶原羧基末端前肽水平
World J Surg. 1996 Sep;20(7):753-6; discussion 756-7. doi: 10.1007/s002689900114.
4
Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.口服阿仑膦酸钠对老年骨质疏松症合并轻度原发性甲状旁腺功能亢进患者的影响。
J Bone Miner Res. 2001 Jan;16(1):113-9. doi: 10.1359/jbmr.2001.16.1.113.
5
Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism.甲状旁腺功能亢进患者骨量丢失及骨代谢血清标志物的评估。
Surg Today. 1995;25(7):598-604. doi: 10.1007/BF00311432.
6
Serum concentrations of carboxyterminal cross-linked telopeptide of type I collagen (ICTP), serum tartrate resistant acid phosphatase, and serum levels of intact parathyroid hormone in parathyroid hyperfunction.甲状旁腺功能亢进时血清I型胶原羧基末端交联肽(ICTP)浓度、血清抗酒石酸酸性磷酸酶及血清完整甲状旁腺激素水平
Scand J Clin Lab Invest. 1994 Feb;54(1):11-5. doi: 10.3109/00365519409086504.
7
Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.原发性甲状旁腺功能亢进症:手术治疗前及治疗后3年的骨骼结构、平衡和重塑
Bone. 2000 May;26(5):535-43. doi: 10.1016/S8756-3282(00)00260-X.
8
Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.甲状旁腺切除术治疗原发性甲状旁腺功能亢进可诱导正向解偶联并增加松质骨的骨矿物质密度。
Clin Endocrinol (Oxf). 2000 Feb;52(2):203-9. doi: 10.1046/j.1365-2265.2000.00900.x.
9
Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.甲状旁腺激素输注及原发性甲状旁腺功能亢进对I型胶原形成和分解的影响。
Calcif Tissue Int. 1994 Dec;55(6):412-6. doi: 10.1007/BF00298553.
10
Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.维持性透析患者长期静脉注射骨化三醇治疗期间骨标志物的变化。
Miner Electrolyte Metab. 1996;22(4):219-23.

引用本文的文献

1
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.再探甲状旁腺疾病中的骨:来自流行病学、手术及新药疗效的证据
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
2
24-hour Urine Calcium Predicts Reduced Fracture Incidence and Improved Bone Mineral Density After Surgery for Primary Hyperparathyroidism.24 小时尿钙可预测原发性甲状旁腺功能亢进症手术后骨折发生率降低和骨密度改善。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2273-e2282. doi: 10.1210/clinem/dgae106.
3
Bone Turnover Markers: Basic Biology to Clinical Applications.
骨转换标志物:基础生物学与临床应用。
Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.
4
Effects of preoperative calcium levels and parathyroidectomy on renal function in primary hyperparathyroidism: a retrospective study.术前血钙水平及甲状旁腺切除术对原发性甲状旁腺功能亢进症肾功能的影响:一项回顾性研究
Croat Med J. 2020 Feb 29;61(1):33-39. doi: 10.3325/cmj.2020.61.33.
5
Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism.肾小管甲状旁腺激素/甲状旁腺激素受体信号传导中断以及肾小管细胞活力受损,可能引发晚期甲状旁腺功能亢进患者术后肾损伤。
Clin Kidney J. 2019 Jan 28;12(5):686-692. doi: 10.1093/ckj/sfy136. eCollection 2019 Oct.
6
Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?使用原发性甲状旁腺功能亢进症骨代谢生化标志物预测成功甲状旁腺切除术后的骨量变化:它在临床上有用吗?
Arch Endocrinol Metab. 2019 Jul 29;63(4):394-401. doi: 10.20945/2359-3997000000154.
7
Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort study.手术治疗与保守治疗的原发性甲状旁腺功能亢进门诊患者小梁骨评分与生物化学指标的相关性:一项回顾性队列研究。
Bone Rep. 2018 Aug 9;9:101-109. doi: 10.1016/j.bonr.2018.08.001. eCollection 2018 Dec.
8
Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.原发性甲状旁腺功能亢进症中骨转换标志物的变化及对手术的反应。
Ann R Coll Surg Engl. 2017 Sep;99(7):559-562. doi: 10.1308/rcsann.2017.0092.
9
Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.原发性甲状旁腺功能亢进症的当代医学管理:一项系统评价。
Front Endocrinol (Lausanne). 2017 Apr 20;8:79. doi: 10.3389/fendo.2017.00079. eCollection 2017.
10
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.原发性甲状旁腺功能亢进症:关于评估、诊断和管理的综述与建议。加拿大及国际共识。
Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9.